Search research articles
Contact Us
Filters
Showing results (31-40 of 35) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 35 results.
The Biochemical Journal
|
August 15, 1995
1 alpha,24(S)-dihydroxyvitamin D2: a biologically active product of 1 alpha-hydroxyvitamin D2 made in the human hepatoma, Hep3B
S Strugnell, V Byford, H L Makin, et al.
Kidney International
|
January 1, 1997
Effective suppression of parathyroid hormone by 1 alpha-hydroxy-vitamin D2 in hemodialysis patients with moderate to severe secondary hyperparathyroidism
A U Tan, B S Levine, R B Mazess, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 17, 1998
Unique 24-hydroxylated metabolites represent a significant pathway of metabolism of vitamin D2 in humans: 24-hydroxyvitamin D2 and 1,24-dihydroxyvitamin D2 detectable in human serum
E B Mawer, G Jones, M Davies, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
September 8, 2000
Intermittent doxercalciferol (1alpha-hydroxyvitamin D(2)) therapy for secondary hyperparathyroidism
J M Frazão, L Elangovan, H M Maung, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
March 3, 2001
Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1alpha-hydroxyvitamin D(2)) in dialysis patients with secondary hyperparathyroidism: a sequential comparison
H M Maung, L Elangovan, J M Frazão, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 35) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 35 results.
The Biochemical Journal
|
August 15, 1995
1 alpha,24(S)-dihydroxyvitamin D2: a biologically active product of 1 alpha-hydroxyvitamin D2 made in the human hepatoma, Hep3B
S Strugnell, V Byford, H L Makin, et al.
Kidney International
|
January 1, 1997
Effective suppression of parathyroid hormone by 1 alpha-hydroxy-vitamin D2 in hemodialysis patients with moderate to severe secondary hyperparathyroidism
A U Tan, B S Levine, R B Mazess, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 17, 1998
Unique 24-hydroxylated metabolites represent a significant pathway of metabolism of vitamin D2 in humans: 24-hydroxyvitamin D2 and 1,24-dihydroxyvitamin D2 detectable in human serum
E B Mawer, G Jones, M Davies, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
September 8, 2000
Intermittent doxercalciferol (1alpha-hydroxyvitamin D(2)) therapy for secondary hyperparathyroidism
J M Frazão, L Elangovan, H M Maung, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
March 3, 2001
Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1alpha-hydroxyvitamin D(2)) in dialysis patients with secondary hyperparathyroidism: a sequential comparison
H M Maung, L Elangovan, J M Frazão, et al.
Page
of 4